Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A

172Citations
Citations of this article
177Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objective: To determine whether lutein supplementation will slow visual function decline in patients with retinitis pigmentosa receiving vitamin A. Design: Randomized, controlled, double-masked trial of 225 nonsmoking patients, aged 18 to 60 years, evaluated over a 4-year interval. Patients received 12 mg of lutein or a control tablet daily. All were given 15 000 IU/d of vitamin A palmitate. Randomization took into account genetic type and baseline serum lutein level. Main Outcome Measures: The primary outcome was the total point score for the Humphrey Field Analyzer (HFA) 30-2 program; prespecified secondary outcomes were the total point scores for the 60-4 program and for the 30-2 and 60-4 programs combined, 30-Hz electroretinogram amplitude, and Early Treatment Diabetic Retinopathy Study acuity. Results:No significant difference in rate of decline was found between the lutein plus vitaminAand control plus vitamin A groups over a 4-year interval for the HFA 30-2 program. For the HFA60-4 program, a decrease in mean rate of sensitivity loss was observed in the lutein plus vitaminAgroup (P=.05). Mean decline with the 60-4 program was slower among those with the highest serum lutein level or with the highest increase in macular pigment optical density at follow-up (P=.01 andP=.006, respectively). Those with the highest increase in macular pigment optical density also had the slowest decline in HFA 30-2 and 60-4 combined field sensitivity (P=.005).Nosignificant toxic effects of lutein supplementation were observed. Conclusion: Lutein supplementation of 12 mg/d slowed loss of midperipheral visual field on average among nonsmoking adults with retinitis pigmentosa taking vitamin A. Application to Clinical Practice: Data are presented that support use of 12 mg/d of lutein to slow visual field loss among nonsmoking adults with retinitis pigmentosa taking vitamin A. Trial Registration: ClinicalTrials.gov Identifier: NCT00346333. ©2010 American Medical Association. All rights reserved.

Cite

CITATION STYLE

APA

Berson, E. L., Rosner, B., Sandberg, M. A., Weigel-DiFranco, C., Brockhurst, R. J., Hayes, K. C., … Schaefer, E. J. (2010). Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A. Archives of Ophthalmology, 128(4), 403–411. https://doi.org/10.1001/archophthalmol.2010.32

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free